Fortrea Holdings Inc
FTRE
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.46B
Close$
$9.23
40.9% downside
Current Fair Value
40.9% downsideOvervalued by 40.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.46 Billion |
|---|---|
| Enterprise Value | $1.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-10.81 |
| Beta | 1.91 |
| Outstanding Shares | 91,200,000 |
Return
| Return on Equity | -84.98% |
|---|---|
| Return on Assets | -16.65% |
| Return on Invested Capital | -20.67% |
Valuation & Multiples
| P/E Ratio | -3.14 |
|---|---|
| PEG | 3.28 |
| Price to Sales | 0.54 |
| Price to Book Ratio | 3.13 |
| Enterprise Value to Revenue | 0.69 |
| Enterprise Value to EBIT | -5.14 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 1.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$0.07
Average shareholder expectationRevenue Estimate
$643.89 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$649.55 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0139▼ 0.98% |
|---|---|
| Total Calls | 972,200▲ 296.82% |
| Total Puts | 13,500▲ 132.76% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 109.63%▲ 5.14% |
|---|---|
| Total Invested | $942.29M▼ 42.69% |
| Investors Holding | 331▼ 19.00% |
ESG Score
No data
About Fortrea Holdings Inc
Relevant Senate Committees
Appropriations
This committee controls federal spending, including allocations to agencies like the NIH, CDC, and FDA. Funding levels for scientific research and public health initiatives directly impact demand for Fortrea's services.
Health, Education, Labor, and Pensions
This committee directly regulates the FDA and NIH, which are critical to Fortrea's operations (drug approval processes, research funding). Labor laws also directly impact a service-based CRO's costs and workforce.